4//SEC Filing
SHERWIN STEPHEN A 4
Accession 0000914475-25-000071
CIK 0000914475other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:49 PM ET
Size
5.3 KB
Accession
0000914475-25-000071
Insider Transaction Report
Form 4
SHERWIN STEPHEN A
Director
Transactions
- Sale
Common Stock
2025-02-13$116.69/sh−13,831$1,613,923→ 10,673 total
Footnotes (2)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.79 to $118.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001079462
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:49 PM ET
- Size
- 5.3 KB